18 O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases
Technological innovations and translation of basic discoveries to clinical practice drive advances in medicine. Today’s innovative technologies enable comprehensive screening of the genome, transcriptome, proteome, and metabolome. The detailed knowledge, converged in the integrated “omics” (genomics...
Gespeichert in:
| Veröffentlicht in: | Croatian medical journal 2012-12, Vol.53 (6), p.529 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 529 |
| container_title | Croatian medical journal |
| container_volume | 53 |
| creator | Nemutlu, Emirhan Zhang, Song Juranic, Nenad O. Terzic, Andre Macura, Slobodan Dzeja, Petras |
| description | Technological innovations and translation of basic discoveries
to clinical practice drive advances in medicine.
Today’s innovative technologies enable comprehensive
screening of the genome, transcriptome, proteome, and
metabolome. The detailed knowledge, converged in the
integrated “omics” (genomics, transcriptomics, proteomics,
and metabolomics), holds an immense potential for understanding
mechanism of diseases, facilitating their early
diagnostics, selecting personalized therapeutic strategies,
and assessing their effectiveness. Metabolomics is the
newest “omics” approach aimed to analyze large metabolite
pools. The next generation of metabolomic screening
requires technologies for high throughput and robust
monitoring of metabolite levels and their fluxes. In this regard,
stable isotope 18O-based metabolite tagging technology
expands quantitative measurements of metabolite
levels and turnover rates to all metabolites that include
water as a reactant, most notably phosphometabolites.
The obtained profiles and turnover rates are sensitive indicators
of energy and metabolic imbalances like the ones
created by genetic deficiencies, myocardial ischemia, heart
failure, neurodegenerative disorders, etc. Here we describe
and discuss briefly the potential use of dynamic phosphometabolomic
platform for disease diagnostics currently
under development at Mayo Clinic. |
| format | Article |
| fullrecord | <record><control><sourceid>hrcak</sourceid><recordid>TN_cdi_hrcak_primary_oai_hrcak_srce_hr_94954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_hrcak_srce_hr_94954</sourcerecordid><originalsourceid>FETCH-hrcak_primary_oai_hrcak_srce_hr_949543</originalsourceid><addsrcrecordid>eNqViksKwjAURYMoWD97yAIspCYt7VgUZ06cl2eT6tMmkbxU0NVb0Q04uod7zoglmZTrtMyKYswSIXOZVrlQUzYjugqxFkoVCYOs5IcUiJCi0Vw_HVhsuDURTr7zAxNvfeDoND5Q99Dh69MhnJ2n-NHgNI_BQLTGRe5bfuktuCEhA2RowSYtdGSWv52z1W573OzTS2jgVt8DWgjP2gPW34dCYwasK1XlSv6ZvwEo7U_W</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>18 O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Nemutlu, Emirhan ; Zhang, Song ; Juranic, Nenad O. ; Terzic, Andre ; Macura, Slobodan ; Dzeja, Petras</creator><creatorcontrib>Nemutlu, Emirhan ; Zhang, Song ; Juranic, Nenad O. ; Terzic, Andre ; Macura, Slobodan ; Dzeja, Petras</creatorcontrib><description>Technological innovations and translation of basic discoveries
to clinical practice drive advances in medicine.
Today’s innovative technologies enable comprehensive
screening of the genome, transcriptome, proteome, and
metabolome. The detailed knowledge, converged in the
integrated “omics” (genomics, transcriptomics, proteomics,
and metabolomics), holds an immense potential for understanding
mechanism of diseases, facilitating their early
diagnostics, selecting personalized therapeutic strategies,
and assessing their effectiveness. Metabolomics is the
newest “omics” approach aimed to analyze large metabolite
pools. The next generation of metabolomic screening
requires technologies for high throughput and robust
monitoring of metabolite levels and their fluxes. In this regard,
stable isotope 18O-based metabolite tagging technology
expands quantitative measurements of metabolite
levels and turnover rates to all metabolites that include
water as a reactant, most notably phosphometabolites.
The obtained profiles and turnover rates are sensitive indicators
of energy and metabolic imbalances like the ones
created by genetic deficiencies, myocardial ischemia, heart
failure, neurodegenerative disorders, etc. Here we describe
and discuss briefly the potential use of dynamic phosphometabolomic
platform for disease diagnostics currently
under development at Mayo Clinic.</description><identifier>ISSN: 0353-9504</identifier><identifier>EISSN: 1332-8166</identifier><identifier>CODEN: CMEJEN</identifier><language>eng</language><publisher>Medicinski fakultet Sveučilišta u Zagrebu, Medicinski fakultet Sveučilišta u Splitu, Medicinski fakultet Sveučilišta u Rijeci</publisher><ispartof>Croatian medical journal, 2012-12, Vol.53 (6), p.529</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttps://hrcak.srce.hr/logo_broj/7664.jpg</thumbnail><link.rule.ids>230,314,776,780,881</link.rule.ids></links><search><creatorcontrib>Nemutlu, Emirhan</creatorcontrib><creatorcontrib>Zhang, Song</creatorcontrib><creatorcontrib>Juranic, Nenad O.</creatorcontrib><creatorcontrib>Terzic, Andre</creatorcontrib><creatorcontrib>Macura, Slobodan</creatorcontrib><creatorcontrib>Dzeja, Petras</creatorcontrib><title>18 O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases</title><title>Croatian medical journal</title><description>Technological innovations and translation of basic discoveries
to clinical practice drive advances in medicine.
Today’s innovative technologies enable comprehensive
screening of the genome, transcriptome, proteome, and
metabolome. The detailed knowledge, converged in the
integrated “omics” (genomics, transcriptomics, proteomics,
and metabolomics), holds an immense potential for understanding
mechanism of diseases, facilitating their early
diagnostics, selecting personalized therapeutic strategies,
and assessing their effectiveness. Metabolomics is the
newest “omics” approach aimed to analyze large metabolite
pools. The next generation of metabolomic screening
requires technologies for high throughput and robust
monitoring of metabolite levels and their fluxes. In this regard,
stable isotope 18O-based metabolite tagging technology
expands quantitative measurements of metabolite
levels and turnover rates to all metabolites that include
water as a reactant, most notably phosphometabolites.
The obtained profiles and turnover rates are sensitive indicators
of energy and metabolic imbalances like the ones
created by genetic deficiencies, myocardial ischemia, heart
failure, neurodegenerative disorders, etc. Here we describe
and discuss briefly the potential use of dynamic phosphometabolomic
platform for disease diagnostics currently
under development at Mayo Clinic.</description><issn>0353-9504</issn><issn>1332-8166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqViksKwjAURYMoWD97yAIspCYt7VgUZ06cl2eT6tMmkbxU0NVb0Q04uod7zoglmZTrtMyKYswSIXOZVrlQUzYjugqxFkoVCYOs5IcUiJCi0Vw_HVhsuDURTr7zAxNvfeDoND5Q99Dh69MhnJ2n-NHgNI_BQLTGRe5bfuktuCEhA2RowSYtdGSWv52z1W573OzTS2jgVt8DWgjP2gPW34dCYwasK1XlSv6ZvwEo7U_W</recordid><startdate>20121215</startdate><enddate>20121215</enddate><creator>Nemutlu, Emirhan</creator><creator>Zhang, Song</creator><creator>Juranic, Nenad O.</creator><creator>Terzic, Andre</creator><creator>Macura, Slobodan</creator><creator>Dzeja, Petras</creator><general>Medicinski fakultet Sveučilišta u Zagrebu, Medicinski fakultet Sveučilišta u Splitu, Medicinski fakultet Sveučilišta u Rijeci</general><scope>VP8</scope></search><sort><creationdate>20121215</creationdate><title>18 O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases</title><author>Nemutlu, Emirhan ; Zhang, Song ; Juranic, Nenad O. ; Terzic, Andre ; Macura, Slobodan ; Dzeja, Petras</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-hrcak_primary_oai_hrcak_srce_hr_949543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nemutlu, Emirhan</creatorcontrib><creatorcontrib>Zhang, Song</creatorcontrib><creatorcontrib>Juranic, Nenad O.</creatorcontrib><creatorcontrib>Terzic, Andre</creatorcontrib><creatorcontrib>Macura, Slobodan</creatorcontrib><creatorcontrib>Dzeja, Petras</creatorcontrib><collection>Hrcak: Portal of scientific journals of Croatia</collection><jtitle>Croatian medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nemutlu, Emirhan</au><au>Zhang, Song</au><au>Juranic, Nenad O.</au><au>Terzic, Andre</au><au>Macura, Slobodan</au><au>Dzeja, Petras</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>18 O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases</atitle><jtitle>Croatian medical journal</jtitle><date>2012-12-15</date><risdate>2012</risdate><volume>53</volume><issue>6</issue><spage>529</spage><pages>529-</pages><issn>0353-9504</issn><eissn>1332-8166</eissn><coden>CMEJEN</coden><abstract>Technological innovations and translation of basic discoveries
to clinical practice drive advances in medicine.
Today’s innovative technologies enable comprehensive
screening of the genome, transcriptome, proteome, and
metabolome. The detailed knowledge, converged in the
integrated “omics” (genomics, transcriptomics, proteomics,
and metabolomics), holds an immense potential for understanding
mechanism of diseases, facilitating their early
diagnostics, selecting personalized therapeutic strategies,
and assessing their effectiveness. Metabolomics is the
newest “omics” approach aimed to analyze large metabolite
pools. The next generation of metabolomic screening
requires technologies for high throughput and robust
monitoring of metabolite levels and their fluxes. In this regard,
stable isotope 18O-based metabolite tagging technology
expands quantitative measurements of metabolite
levels and turnover rates to all metabolites that include
water as a reactant, most notably phosphometabolites.
The obtained profiles and turnover rates are sensitive indicators
of energy and metabolic imbalances like the ones
created by genetic deficiencies, myocardial ischemia, heart
failure, neurodegenerative disorders, etc. Here we describe
and discuss briefly the potential use of dynamic phosphometabolomic
platform for disease diagnostics currently
under development at Mayo Clinic.</abstract><pub>Medicinski fakultet Sveučilišta u Zagrebu, Medicinski fakultet Sveučilišta u Splitu, Medicinski fakultet Sveučilišta u Rijeci</pub><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0353-9504 |
| ispartof | Croatian medical journal, 2012-12, Vol.53 (6), p.529 |
| issn | 0353-9504 1332-8166 |
| language | eng |
| recordid | cdi_hrcak_primary_oai_hrcak_srce_hr_94954 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| title | 18 O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A11%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hrcak&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=18%20O-assisted%20dynamic%20metabolomics%20for%20individualized%20diagnostics%20and%20treatment%20of%20human%20diseases&rft.jtitle=Croatian%20medical%20journal&rft.au=Nemutlu,%20Emirhan&rft.date=2012-12-15&rft.volume=53&rft.issue=6&rft.spage=529&rft.pages=529-&rft.issn=0353-9504&rft.eissn=1332-8166&rft.coden=CMEJEN&rft_id=info:doi/&rft_dat=%3Chrcak%3Eoai_hrcak_srce_hr_94954%3C/hrcak%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |